Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

68%

17 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (8)
P 4 (9)

Trial Status

Completed17
Unknown6
Not Yet Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07312721Phase 4Completed

Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

NCT05021029Enrolling By Invitation

UC Davis Cohort of Pre-Malignant and Malignant Gastro-Intestinal DisEases Study

NCT07139886Phase 2Completed

A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration

NCT07129824Not Yet RecruitingPrimary

Relationship Between Diet and Gastritis

NCT06514274Phase 4Completed

Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

NCT06603688Phase 4Unknown

Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

NCT05048069Unknown

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

NCT04697186Phase 4Completed

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

NCT05014334Phase 4Completed

Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication

NCT05666531Unknown

Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously

NCT05073614Not ApplicableCompletedPrimary

Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis

NCT04341454Phase 3Completed

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

NCT01817556Phase 4Completed

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

NCT04189705Phase 3Completed

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

NCT04066530Phase 3Completed

A Study to Evaluate the Efficacy and Safety of AD-203

NCT03847753Completed

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

NCT03609892Phase 4Completed

Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

NCT02658864Phase 1CompletedPrimary

Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets

NCT02356679Phase 4Completed

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

NCT02219529Phase 3Completed

Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases

Scroll to load more

Research Network

Activity Timeline